Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

BACKGROUND: The objective of this study was to estimate the cost-effectiveness of denosumab for fracture prevention compared with no treatment, generic bisphosphonates, and strontium ranelate in a cohort of osteoporotic postmenopausal women in Spain. METHODS: A Markov model represented the possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Darbà, Josep, Kaskens, Lisette, Sorio Vilela, Francesc, Lothgren, Mickael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330002/
https://www.ncbi.nlm.nih.gov/pubmed/25709480
http://dx.doi.org/10.2147/CEOR.S78349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330002/
https://www.ncbi.nlm.nih.gov/pubmed/25709480
http://dx.doi.org/10.2147/CEOR.S78349

Ejemplares similares